Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Sarcoidosis often involves the liver. However, primary hepatic sarcoidosis confined to the liver without evidence of systemic involvement is rare. We report the case of a 37-year-old man with hepatic sarcoidosis who initially presented with elevated liver enzymes and suspicious cirrhotic nodules on computed tomography. The patient had cirrhosis but did not have portal hypertension. Based on the initial histopathologic finding of chronic granulomatous inflammation and the common clinical characteristics of sarcoidosis, he was initially diagnosed with primary biliary cholangitis, and his daily dosage of ursodeoxycholic acid was increased to 900 mg. After 14 months of treatment, his total serum bilirubin concentration was 10.9 mg/dL (upper normal limit, 1.2 mg/dL). Additionally, a transjugular liver biopsy revealed multiple noncaseating granulomas. He was diagnosed with primary hepatic sarcoidosis involving the lungs, heart, spleen, kidneys, and skin. Treatment with methylprednisolone was initiated. Two weeks later, he was started on azathioprine, and the dose of steroid was simultaneously reduced. These findings indicate the importance of including hepatic sarcoidosis as a possible diagnosis in patients with elevated liver enzymes or cryptogenic cirrhosis.
Abstract
Sarcoidosis often involves the liver. However, primary hepatic sarcoidosis confined to the liver without evidence of systemic involvement is rare. We report the case of a 37-year-old man with hepatic sarcoidosis who initially presented with elevated liver enzymes and suspicious cirrhotic nodules on computed tomography. The patient had cirrhosis but did not have portal hypertension. Based on the initial histopathologic finding of chronic granulomatous inflammation and the common clinical characteristics of sarcoidosis, he was initially diagnosed with primary biliary cholangitis, and his daily dosage of ursodeoxycholic acid was increased to 900 mg. After 14 months of treatment, his total serum bilirubin concentration was 10.9 mg/dL (upper normal limit, 1.2 mg/dL). Additionally, a transjugular liver biopsy revealed multiple noncaseating granulomas. He was diagnosed with primary hepatic sarcoidosis involving the lungs, heart, spleen, kidneys, and skin. Treatment with methylprednisolone was initiated. Two weeks later, he was started on azathioprine, and the dose of steroid was simultaneously reduced. These findings indicate the importance of including hepatic sarcoidosis as a possible diagnosis in patients with elevated liver enzymes or cryptogenic cirrhosis.
참고문헌 (20)
- Ebert EC, "Gastrointestinal and hepatic manifestations of sarcoidosis", Am J Gastroenterol, 103, pp.3184~3192 (2008)
- Mueller S, "Extrapulmonary sarcoidosis primarily diagnosed in the liver", Scand J Gastroenterol, 35, pp.1003~1008 (2000)
- Judson MA, "Hepatic, splenic, and gastrointestinal involvement with sarcoidosis", Semin Respir Crit Care Med, 23, pp.529~541 (2002)
- Ishak KG, "Sarcoidosis of the liver and bile ducts", Mayo Clin Proc, 73, pp.467~472 (1998)
- Blich M, "Clinical manifestations of sarcoid liver disease", J Gastroenterol Hepatol, 19, pp.732~737 (2004)
- Cremers J, "Liver-test abnormalities in sarcoidosis", Eur J Gastroenterol Hepatol, 24, pp.17~24 (2012)
- Kennedy PT, "Natural history of hepatic sarcoidosis and its response to treatment", Eur J Gastroenterol Hepatol, 18, pp.721~726 (2006)
- Maddrey WC, "Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients", Medicine(Baltimore), 49, pp.375~395 (1970)
- Ungprasert P, "Clinical characteristics and outcome of hepatic sarcoidosis : a population-based study 1976-2013", Am J Gastroenterol, 112, pp.1556~1563 (2017)
- Bihari C, "Hepatic sarcoidosis : clinico-pathological characterization of symptomatic cases", Acta Gastroenterol Belg, 78, pp.306~313 (2015)
- Devaney K, "Hepatic sarcoidosis. Clinicopathologic features in 100 patients", Am J Surg Pathol, 17, pp.1272~1280 (1993)
- Karagiannidis A, "Hepatic sarcoidosis", Ann Hepatol, 5, pp.251~256 (2006)
- Giovinale M, "Atypical sarcoidosis : case reports and review of the literature", Eur Rev Med Pharmacol Sci, 13(Suppl 1), pp.37~44 (2009)
- Flamm SL, "Granulomatous liver disease", Clin Liver Dis, 16, pp.387~396 (2012)
- Syed U, "Hepatic sarcoidosis : pathogenesis, clinical context, and treatment options", Scand J Gastroenterol, 51, pp.1025~1030 (2016)
- Tadros M, "Hepatic Sarcoidosis", J Clin Transl Hepatol, 1, pp.87~93 (2013)
- Modaresi Esfeh J, "Clinical presentation and protocol for management of hepatic sarcoidosis", Expert Rev Gastroenterol Hepatol, 9, pp.349~358 (2015)
- Bunting PS, "Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis", Clin Biochem, 20, pp.213~219 (1987)
- Kessler A, "Hepatic and splenic sarcoidosis : ultrasound and MR imaging", Abdom Imaging, 18, pp.159~163 (1993)
- Cremers JP, "Therapeutic approach of hepatic sarcoidosis", Curr Opin Pulm Med, 18, pp.472~482 (2012)